These results showed that AS/LIG/AS_LIG@PPGC NPs could modulate the NOX4/NLRP3/p38 MAPK signaling pathway in IPF, thereby alleviating pulmonary inflammation and fibrosis levels. The gene discussed is NLRP3; the disease is idiopathic pulmonary fibrosis.